Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis
about
sameAs
Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismAntiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome systemControl of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 GenesB-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signalingCancer biomarker discovery: the entropic hallmark.A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancerUp-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarrayLSOSS: Detection of Cancer Outlier Differential Gene ExpressionAndrogen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression.Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells.Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients.B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating IκBα degradation in normal and cancer cells.B cell translocation gene 2 (Btg2) is regulated by Stat3 signaling and inhibits adipocyte differentiation.Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.Androgen receptor and miR-206 regulation in prostate cancer.TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells.C. elegans FOG-3/Tob can either promote or inhibit germline proliferation, depending on gene dosage and genetic context.BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria.L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence.B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.Proteasome inhibitors and their combination with antiandrogens: effects on apoptosis, cellular proliferation and viability of prostatic adenocarcinoma cell cultures.BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/BBC3 and BTG2.Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2/TIS21 via downregulating cytoplasmic nucleolin expression.BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma.Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model.Estradiol Prevents High Glucose-Induced β-cell Apoptosis by Decreased BTG2 Expression
P2860
Q26774456-00280066-401A-48D0-B136-F9A7AA80F7CEQ28215637-ED233AD0-5B79-4250-B68F-D9ADAB95E17FQ28261895-E74CA633-905F-4E1B-90DE-39B282190D75Q28506138-80E8C5E6-414E-43D1-B1CC-FA8B3C5AA97FQ30496149-E8B92730-43C9-4EE8-8D30-5F55998898D2Q33231831-CD80CF82-3CD8-400E-87C7-C823605E0271Q33455595-7AD24ADB-5D95-417E-A447-051175787460Q33606254-62810A3D-33BF-4234-8D87-26433272CD45Q34052667-09E217C0-0534-4241-9444-3F8036CB498AQ34248844-972B42C7-04F5-4BB8-ACEE-EB9771F08352Q34531716-85B97A64-5BFD-42FB-B64B-5F361964A131Q34988330-7CE7D266-640B-4303-9668-3C4290F1C99AQ36225828-50A8E8A6-23CF-4FE1-B88D-FA76D4CE47C0Q36663570-9C70C00B-DE4B-4B41-B466-7FF68FFF612EQ37365789-A77A3A30-2DFF-423E-89F0-05B5ADE2964FQ38806143-2E4036D5-7A4C-4A6D-8564-4888D5960EA6Q38896410-2C4BE00B-1386-4824-9200-EFC4D6AD6025Q38946793-67A2DBF2-83AF-48FA-B68B-78525A55DA64Q39116768-34BFF6D5-A62F-43C1-BC3B-72301C9C8CFFQ39119017-4352A53B-DD07-47FC-9F0A-07346B72F733Q39344938-399AC49C-659C-4DDF-8313-77364CEE4385Q39352908-9CEC9CBE-2EC3-46E7-B1B7-2611663507EEQ39437475-CD6CBF0C-6104-4DD2-A933-424057EA7533Q39502702-C92D615A-0ECA-44BC-A307-7FCD42E769B8Q39590768-AF8EF682-1719-4F24-A69B-9B3A44F294C4Q39994602-759F606B-DD80-4691-8D9F-73E2C09CC521Q40731795-BBF35608-B5F2-4EFA-BE55-27954BA4058CQ42184828-DC8F2491-35AD-45A4-A9B2-AC0C7C39664BQ42490158-75A9101D-B2C2-48E7-BA07-285487A61A45Q44833962-BF335E96-05AA-49E3-BEE6-1D9043B83EBFQ47446427-57BE5D8C-A32B-4717-BC94-BF236262BDC5Q48204505-AE24192B-5321-4CE3-A26D-8CF5CD771AE1Q52689090-197B0E0F-3297-482A-90F9-D9AD5ACE8B4CQ52965377-03EFB360-E2CC-4F89-9058-6446B855899EQ54256077-15E31615-78BF-4ECA-8C9E-3C4B7ABA8D00Q58774687-6969050B-D3F6-4720-919B-1B2A265D11A2
P2860
Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@ast
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@en
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@nl
type
label
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@ast
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@en
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@nl
prefLabel
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@ast
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@en
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@nl
P2093
P356
P1433
P1476
Antiproliferative B cell trans ...... ent in prostate carcinogenesis
@en
P2093
P304
P356
10.1093/CARCIN/22.8.1271
P407
P577
2001-08-01T00:00:00Z